Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

French ultrasound threatened by cost of errors

This article was originally published in Clinica

Executive Summary

The legal cases of three French children whose handicaps were not detected during antenatal ultrasound procedures have cast a shadow over the future of ultrasound practice in France. If the courts rule in favour of the children and award large settlements, according to a precedent set for undiagnosed handicap, then sonographers fear their insurance premiums would rise five- or ten-fold and price them out of practice, according to Le Quotidien du Medecin.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT070081

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel